Rippon: Channel 4 ADHD Doc Was Not Science-Led — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Channel 4 aired a documentary titled 'The Great ADHD Myth?' whose press release framed the inquiry as determining whether ADHD is a 'genuine neurodevelopmental disorder, or a social construct' — a binary the WHO and NHS, which recognize ADHD, would reject
- ADHD affects roughly 8% of children and adolescents and about 3% of adults worldwide, yet the documentary never engaged the genetic and developmental research supporting that consensus, according to Rippon
- Max Pemberton, a doctor and the documentary's presenter, had already published skeptical ADHD pieces including a Daily Mail article headlined 'This is the REAL reason why there's been an explosion in cases of ADHD', undermining the claim of an open-minded investigation
- Prof Katya Rubia, a cognitive neuroscientist with an ADHD research track record, told Pemberton that MRI scans show small group-level brain differences — a finding backed by a 2017 landmark study combining scans from over 3,000 people, which Pemberton's questioning sidestepped
- The documentary's central 'experiments' included taking 10-year-old Mason off ADHD medication for six weeks while also removing screens and ultra-processed food, with no control conditions, and Pemberton's own £1,200 private online assessment that produced a near-instant ADHD diagnosis
- Rippon argues a flawed diagnostic process does not invalidate the disorder it measures, and that legitimate questions about diagnostic thresholds, private assessment rigor, and stimulant medication use do not require dismissing decades of neuroscientific evidence
Why it matters: The documentary's framing matters because ADHD diagnoses — delivered under Nice guidelines and recognized by the WHO — affect treatment access for millions; if the public accepts the 'social construct' label on the strength of uncontrolled case studies and a single self-paid online test, patients risk losing clinical credibility for a condition with documented genetic and brain-based correlates.
Ask SkimNews
